Superales, Junrel P.
HRN: 16-41-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2023
CEFUROXIME 1.5GM (VIAL)
04/17/2023
04/23/2023
IV
1.5grams
Q8hours
Femoral Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes